SpotLight of Recent Invention – 2026 BIOASIA

1. Cancer treatment

DBPR728 ─ A Kinase Inhibitor Targeting MYC Driven Cancers

DBPR807/ Therapeutic Application of CXCR4 Antagonist DBPR807 for HCC Treatment

DBPR22998/ A QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPα Axis for Cancer Immunotherapy

LDOC1 IHC-Based Patient Stratification for Predicting EGFR-TKI Treatment Benefit

2. Autoimmune disease treatment

Oral STING covalent inhibitor for autoimmune disease (GHN105)

Oral STING inhibitor for autoimmune disease therapy

3. Metabolic disease treatment

S-Gut FcRn–IgG Checkpoint in Metabolic Inertia

4. Pain treatment

BPR1M492─A Novel and Fast Acting Opioid Analgesic

5. Vaccine manufacturing platforms

Surface engineering of lipid nanoparticle in the pursuit of innovative nucleic acid-based vaccines and therapeutics

Constructing colloidal delivery vehicles based on amphiphilic bioresorbable copolymers for vaccines and therapeutics

6. Regenerative Medicine & Research Platforms

A substance and applied method to sustain the self-renewal of hair follicle stem cells

A composition and method to make reconstructed human skin equivalent

AI-PRS Precision Medicine & Zebrafish Translational Platform

Taiwan Zebrafish Core Facility